GRI Bio, Inc.
GRI
$1.56
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.90% | 26.68% | 37.05% | 37.88% | 28.12% |
| Total Depreciation and Amortization | -2,600.00% | -1,150.00% | -2,600.00% | -163.64% | -85.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -100.00% |
| Total Other Non-Cash Items | 506.82% | 27.46% | -25.10% | -116.67% | -81.08% |
| Change in Net Operating Assets | 115.02% | 7.10% | -126.67% | -162.81% | -153.95% |
| Cash from Operations | 18.24% | 23.27% | 4.22% | -184.79% | -263.18% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -10.65% | -52.91% | 13.07% | -6.31% | -14.70% |
| Repurchase of Common Stock | -- | -- | -- | 99.19% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -160.89% | 70.68% | 24.98% | 128.94% | 134.39% |
| Cash from Financing | -37.83% | -48.54% | 9.58% | 75.12% | 61.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -179.21% | -122.31% | 78.99% | -62.83% | -67.56% |